Skip to main content

MelroseWakefield Hospital Achieves Zero Central Line Infection Rate

June 17, 2025

MelroseWakefield Hospital reports zero CLABSI cases, ranking among just ten in Massachusetts to achieve this top patient safety milestone, per CMS data.

MelroseWakefield Hospital is one of 339 hospitals across the United States and just one of ten in Massachusetts to record a central line associated bloodstream infection (CLABSI) rate of zero, according to the recently released Healthcare-Associated Infections dataset from Centers for Medicare & Medicaid Services.

CLABSI is a serious hospital-acquired infection that occurs when germs get into the bloodstream through a central line, or catheter which is placed into a patient's arm, neck, chest or groin to give them fluids or medications.

The Healthcare-Associated Infections dataset, updated April 30, includes performance data for five types of infections collected through the CDC's National Healthcare Safety Network. The measures show how often patients in a hospital contract infections during an inpatient stay compared to similar hospitals. The measures apply to all patients treated in acute care hospitals, including adult, pediatric, neonatal, Medicare and non-Medicare patients, according to the CMS data dictionary. Data was collected from July 2023 through June 2024.

"Our team at MelroseWakefield Hospital achieved a CLABSI rate of zero by implementing consistent safety protocols, training staff, and leading with a culture of safety and communication that always puts patient safety first," said Chief Medical Officer Michael DeLeo, MD.

We are proud to have achieved the zero infection rate and are committed to continuously providing the highest quality care.

Chief Medical Officer Michael DeLeo, MD

Chris' Story
Patient Stories
Chris’s Story: Stroke Recovery After a First-of-its-Kind Heart Procedure
December 11, 2025
After a stroke at 29, Chris became the first person in the world to receive a new PFO closure device at Tufts Medical Center and has made a full recovery.
Drs. Thaler and Kimmelstiel
Articles
Tufts Medicine Team Pioneers New Patent Foramen Ovale Closure Device
December 11, 2025
Tufts Medical Center becomes the first site to evaluate the new P3 Occluder System for patent foramen ovale closure, advancing stroke-prevention research.
On the Road with Tufts Medicine: Babies and Bows
On the Road with Tufts Medicine
Babies + Bows
December 9, 2025
Join the action as our care teams deliver exceptional care—and unforgettable moments—for growing families.

Be among the first to know

Enjoy the latest health updates from Tufts Medicine by signing up for our e-newsletter today.

Jump back to top